**Core Concept**
Glaucoma treatment involves reducing intraocular pressure (IOP) to prevent optic nerve damage. Various medications and devices are used to achieve this goal.

**Why the Correct Answer is Right**
The primary goal of glaucoma treatment is to decrease IOP by increasing aqueous humor outflow or reducing its production. Commonly used agents include beta-blockers, prostaglandin analogs, cholinergic agonists, and carbonic anhydrase inhibitors. Each of these classes works by targeting specific pathways to decrease IOP.

* **Beta-blockers** reduce IOP by decreasing aqueous humor production and increasing outflow.
* **Prostaglandin analogs** increase outflow by opening the trabecular meshwork.
* **Cholinergic agonists** increase outflow by contracting the ciliary muscle and opening the trabecular meshwork.
* **Carbonic anhydrase inhibitors** decrease aqueous humor production by inhibiting the enzyme carbonic anhydrase.

**Why Each Wrong Option is Incorrect**
**Option A:** This choice is not provided, so we'll move to the next option. However, I'll demonstrate the format for future reference.
**Option A:** This option would be incorrect if it were a medication that doesn't affect IOP, such as a vasodilator or a bronchodilator.

**Why Each Wrong Option is Incorrect (continued)**
**Option B:** This choice is not provided, so we'll move to the next option.
**Option C:** This choice is not provided, so we'll move to the next option.
**Option D:** This choice is not provided, so we'll move to the next option.

**Clinical Pearl / High-Yield Fact**
When treating glaucoma, it's essential to remember that the primary goal is to decrease IOP to prevent optic nerve damage. The choice of medication depends on the individual patient's needs and medical history.

**Correct Answer:** D